Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 32
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Preferential regional distribution of atrial fibrosis in posterior wall around left inferior pulmonary vein as identified by late gadolinium enhancement cardiac magnetic resonance in patients with atrial fibrillation

  • Benito, Eva M.
  • Cabanelas, Nuno
  • Nuñez-Garcia, Marta
  • Alarcón, Francisco
  • Figueras i Ventura, Rosa M.
  • Soto-Iglesias, David
  • Guasch, Eduard
  • Prat Gonzàlez, Susanna
  • Perea, Rosario J.
  • Borràs, Roger
  • Butakoff, Constantine
  • Camara, Oscar
  • Bisbal, Felipe
  • Arbelo, Elena
  • Tolosana, José Maria
  • Brugada, Josep
  • Berruezo Sánchez, Antonio
  • Mont, Lluís
Aims: Left atrial (LA) fibrosis can be identified by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) in patients with atrial fibrillation (AF). However, there is limited information about anatomical fibrosis distribution in the left atrium. The aim is to determine whether there is a preferential spatial distribution of fibrosis in the left atrium in patients with AF. Methods and results: A 3-Tesla LGE-CMR was performed in 113 consecutive patients referred for AF ablation. Images were post-processed and analysed using ADAS-AF software (Galgo Medical), which allows fibrosis identification in 3D colour-coded shells. A regional semiautomatic LA parcellation software was used to divide the atrial wall into 12 segments: 1–4, posterior wall; 5–6, floor; 7, septal wall; 8–11, anterior wall; 12, lateral wall. The presence and amount of fibrosis in each segment was obtained for analysis. After exclusions for artefacts and insufficient image quality, 76 LGE-MRI images (68%) were suitable for fibrosis analysis. Segments 3 and 5, closest to the left inferior pulmonary vein, had significantly higher fibrosis (40.42% ± 23.96 and 25.82% ± 21.24, respectively; P < 0.001), compared with other segments. Segments 8 and 10 in the anterior wall contained the lowest fibrosis (2.54% ± 5.78 and 3.82% ± 11.59, respectively; P < 0.001). Age >60 years was significantly associated with increased LA fibrosis [95% confidence interval (CI) 0.19–8.39, P = 0.04] and persistent AF approached significance (95% CI −0.19% to 7.83%, P = 0.08). Conclusion: In patients with AF, the fibrotic area is preferentially located at the posterior wall and floor around the antrum of the left inferior pulmonary vein. Age >60 years was associated with increased fibrosis., This work was partially supported by Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III (PI13/01747 and PI16/00435); Agencia de gestió d´Ajuts Universitaris I de Recerca (AGAUR) Exp: 2014_SGR_471; CERCA programme/Generalitat de Catalunya; European Regional Development Fund (ERDF. European Union. A Way of Making Europe), the European Union's Horizon 2020 research and innovation programme under grant agreement No 633196 (CATCH ME), a grant by La MARATÓ-TV3 (20152730) and the Spanish Ministry of Economy and Competitiveness (DPI2015-71640-R).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Optimized single-point left ventricular pacing leads to improved resynchronization compared with multipoint pacing

  • San Antonio, Rodolfo
  • Guasch, Eduard
  • González-Ascaso, Ana
  • Jiménez-Arjona, Rafael
  • Pujol-López, Margarida
  • Doltra, Adelina
  • Alarcón, Francisco
  • Garre, Paz
  • Liberos Mascarell, Alejandro
  • Trotta, Omar
  • Quinto, Levio
  • Borras, Roger
  • Arbelo, Elena
  • Roca-Luque, Ivo
  • Atienza, Felipe
  • Brugada, Josep
  • Fernandez-Aviles, Francisco
  • Sitges, Marta
  • Tolosana, José María
  • Mont, Lluis
  • Andreu M. Climent|||0000-0002-7260-8811
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
[EN] Background Multipoint pacing (MPP) in cardiac resynchronization therapy (CRT) activates the left ventricle from two locations, thereby shortening the QRS duration and enabling better resynchronization; however, compared with conventional CRT, MPP reduces battery longevity. On the other hand, electrocardiogram-based optimization using the fusion-optimized intervals (FOI) method achieves more significant reverse remodeling than nominal CRT programming. Our study aimed to determine whether MPP could attain better resynchronization than single-point pacing (SPP) optimized by FOI. Methods This prospective study included 32 consecutive patients who successfully received CRT devices with MPP capabilities. After implantation, the QRS duration was measured during intrinsic rhythm and with three pacing configurations: MPP, SPP-FOI, and MPP-FOI. In 14 patients, biventricular activation times (by electrocardiographic imaging, ECGI) were obtained during intrinsic rhythm and for each pacing configuration to validate the findings. Device battery longevity was estimated at the 45-day follow-up. Results The SPP-FOI method achieved greater QRS shortening than MPP (-56 +/- 16 vs. -42 +/- 17 ms, p < .001). Adding MPP to the best FOI programming did not result in further shortening (MPP-FOI: -58 +/- 14 ms, p = .69). Although biventricular activation times did not differ significantly among the three pacing configurations, only the two FOI configurations achieved significant shortening compared with intrinsic rhythm. The estimated battery longevity was longer with SPP than with MPP (8.1 +/- 2.3 vs. 6.3 +/- 2.0 years, p = .03). Conclusions SPP optimized by FOI resulted in better resynchronization and longer battery duration than MPP., Centro de Investigacion Biomedica en Red Enfermedades Cardiovasculares, Grant/Award Number: CB16/11/00354; Instituto de Salud Carlos III, Grant/Award Numbers: DTS16/0160, PI16/00435, PI16/00703, PI17/01059, PI17/01106; Sociedad Espanola de Cardiologia, Grant/Award Numbers: 2018, SEC_ESTIM_01; Agencia deGestio d'Ajuts Universitaris i de Recerca, Grant/AwardNumber: 2017_SGR_1548; Fundacio laMarato de TV3, Grant/Award Number: 20152730; Horizon 2020 Framework Programme, Grant/Award Number: 633196 - CATCH MEproject; European Regional Development Fund, Grant/Award Number: EITHealth 19600 AFFINE
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset

  • Chua, Winnie
  • Easter, Christina L.
  • Guasch i Casany, Eduard
  • Sitch, Alice
  • Casadei, Barabara
  • Crijns, Harry J.G.M.
  • Haase, Doreen
  • Hatem Stéphane
  • Kääb, Stefan
  • Mont Girbau, Lluís
  • Schotten, Ulrich
  • Sinner, Moritz F.
  • Hemming, Karla
  • Deeks, Jonathan J.
  • Kirchhof, Paulus
  • Fabritz, Larissa
Background: Atrial fibrillation (AF) is caused by different mechanisms but current treatment strategies do not target these mechanisms. Stratified therapy based on mechanistic drivers and biomarkers of AF have the potential to improve AF prevention and management outcomes. We will integrate mechanistic insights with known pathophysiological drivers of AF in models predicting recurrent AF and prevalent AF to test hypotheses related to AF mechanisms and response to rhythm control therapy. Methods: We will harmonise and combine baseline and outcome data from 12 studies collected by six centres from the United Kingdom, Germany, France, Spain, and the Netherlands which assess prevalent AF or recurrent AF. A Delphi process and statistical selection will be used to identify candidate clinical predictors. Prediction models will be developed in patients with AF for AF recurrence and AF-related outcomes, and in patients with or without AF at baseline for prevalent AF. Models will be used to test mechanistic hypotheses and investigate the predictive value of plasma biomarkers. Discussion: This retrospective, harmonised, individual patient data analysis will use information from 12 datasets collected in five European countries. It is envisioned that the outcome of this analysis would provide a greater understanding of the factors associated with recurrent and prevalent AF, potentially allowing development of stratified approaches to prevention and therapy management.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Preferential regional distribution of atrial fibrosis in posterior wall around left inferior pulmonary vein as identified by late gadolinium enhancement cardíac magnetic resonance in patients with atrial fibrillation

  • Benito, Eva
  • Cabanelas, Nuno
  • Nuñez-Garcia, Marta
  • Alarcón, Francisco
  • Figueras i Ventura, Rosa M.
  • Soto Iglesias, David
  • Guasch i Casany, Eduard
  • Prat González, Susanna
  • Perea Palazón, Rosario Jesús
  • Borràs, Roger
  • Butakoff, Constantine
  • Camara, Oscar
  • Bisbal, Felipe
  • Arbelo, Elena
  • Tolosana, José M. (José María)
  • Brugada Terradellas, Josep, 1958-
  • Berruezo Sánchez, Antonio
  • Mont Girbau, Lluís
Aims: Left atrial (LA) fibrosis can be identified by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) in patients with atrial fibrillation (AF). However, there is limited information about anatomical fibrosis distribution in the left atrium. The aim is to determine whether there is a preferential spatial distribution of fibrosis in the left atrium in patients with AF. Methods and results: A 3-Tesla LGE-CMR was performed in 113 consecutive patients referred for AF ablation. Images were post-processed and analysed using ADAS-AF software (Galgo Medical), which allows fibrosis identification in 3D colour-coded shells. A regional semiautomatic LA parcellation software was used to divide the atrial wall into 12 segments: 1-4, posterior wall; 5-6, floor; 7, septal wall; 8-11, anterior wall; 12, lateral wall. The presence and amount of fibrosis in each segment was obtained for analysis. After exclusions for artefacts and insufficient image quality, 76 LGE-MRI images (68%) were suitable for fibrosis analysis. Segments 3 and 5, closest to the left inferior pulmonary vein, had significantly higher fibrosis (40.42% ± 23.96 and 25.82% ± 21.24, respectively; P < 0.001), compared with other segments. Segments 8 and 10 in the anterior wall contained the lowest fibrosis (2.54% ± 5.78 and 3.82% ± 11.59, respectively; P < 0.001). Age >60 years was significantly associated with increased LA fibrosis [95% confidence interval (CI) 0.19-8.39, P = 0.04] and persistent AF approached significance (95% CI -0.19% to 7.83%, P = 0.08). Conclusion: In patients with AF, the fibrotic area is preferentially located at the posterior wall and floor around the antrum of the left inferior pulmonary vein. Age >60 years was associated with increased fibrosis.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study

  • Bisbal, Felipe
  • Alarcón, Francisco
  • Ferrero, Ángel
  • González Ferrer, Juan José
  • Alonso, Concepción
  • Pachón, Marta
  • Tizón Marcos, Helena
  • Cabanas Grandío, Pilar
  • Sánchez, Manuel
  • Benito, Eva
  • Teis, Albert
  • Ruiz Granell, Ricardo
  • Pérez Villacastín, Julián
  • Viñolas, Xavier
  • Arias, Miguel Ángel
  • Vallès, Ermengol
  • García Campo, Enrique
  • Fernández Lozano, Ignacio
  • Villuendas, Roger
  • Mont Girbau, Lluís
Aims: Left atrial (LA) remodelling is a key determinant of atrial fibrillation (AF) ablation outcome. Optimal methods to assess this process are scarce. LA sphericity is a shape-based parameter shown to be independently associated to procedural success. In a multicentre study, we aimed to test the feasibility of assessing LA sphericity and evaluate its capability to predict procedural outcomes. Methods and results: This study included consecutive patients undergoing first AF ablation during 2013. A 3D model of the LA chamber, excluding pulmonary veins and LA appendage, was used to quantify LA volume (LAV) and LA sphericity (≥82.1% was considered spherical LA). In total, 243 patients were included across 9 centres (71% men, aged 56 ± 10 years, 44% with hypertension and 76% CHA2DS2-VASc ≤ 1). Most patients had paroxysmal AF (66%) and underwent radiofrequency ablation (60%). Mean LA diameter (LAD), LAV, and LA sphericity were 42 ± 6 mm, 100 ± 33 mL, and 82.6 ± 3.5%, respectively. Adjusted Cox models identified paroxysmal AF [hazard ratio (HR 0.54, P = 0.032)] and LA sphericity (HR 1.87, P = 0.035) as independent predictors for AF recurrence. A combined clinical-imaging score [Left Atrial Geometry and Outcome (LAGO)] including five items (AF phenotype, structural heart disease, CHA2DS2-VASc ≤ 1, LAD, and LA sphericity) classified patients at low (≤2 points) and high risk (≥3 points) of procedural failure (35% vs. 82% recurrence at 3-year follow-up, respectively; HR 3.10, P < 0.001). Conclusion: In this multicentre, real-life cohort, LA sphericity and AF phenotype were the strongest predictors of AF ablation outcome after adjustment for covariates. The LAGO score was easy to implement, identified high risk of procedural failure, and could help select optimal candidates. Clinical Trial Registration Information: NCT02373982 (http://clinicaltrials.gov/ct2/show/NCT02373982).
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Diagnosis, pathophysiology, and management of exercise-induced arrhythmias

  • Guasch i Casany, Eduard
  • Mont Girbau, Lluís
The cardiovascular benefits of physical activity are indisputable. Nevertheless, growing evidence suggests that both atrial fibrillation and right ventricular arrhythmia can be caused by intense exercise in some individuals. Exercise-induced atrial fibrillation is most commonly diagnosed in middle-aged, otherwise healthy men who have been engaged in endurance training for >10 years, and is mediated by atrial dilatation, parasympathetic enhancement, and possibly atrial fibrosis. Cardiac ablation is evolving as a first-line tool for athletes with exercise-induced arrhythmia who are eager to remain active. The relationship between physical activity and right ventricular arrhythmia is complex and involves genetic and physical factors that, in a few athletes, eventually lead to right ventricular dilatation, followed by subsequent myocardial fibrosis and lethal ventricular arrhythmias. Sinus bradycardia and atrioventricular conduction blocks are common in athletes, most of whom remain asymptomatic, although incomplete reversibility has been shown after exercise cessation. In this Review, we summarize the evidence supporting the existence of exercise-induced arrhythmias and discuss the specific considerations for the clinical management of these patients.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control study

  • Calvo Galiano, Naiara
  • Ramos, Pablo
  • Montserrat-Vila, Sílvia
  • Guasch i Casany, Eduard
  • Coll-Vinent i Puig, Blanca
  • Doménech, Mónica
  • Bisbal, Felipe
  • Hevia, Sara
  • Vidorreta, Silvia
  • Borràs, Roger
  • Falces Salvador, Carles
  • Embid, Cristina
  • Montserrat Canal, José Ma.
  • Berruezo Sánchez, Antonio
  • Coca, Antonio
  • Sitges Carreño, Marta
  • Brugada Terradellas, Josep, 1958-
  • Mont Girbau, Lluís
A history of a parts per thousand yen2000 h of vigorous endurance training, tall stature, abdominal obesity, and OSA are frequently encountered as risk factors in patients with Ln-AF. Fewer than 2000 total hours of high-intensity endurance training associates with reduced Ln-AF risk.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

JavaCyte, a novel open-source tool for automated quantification of key hallmarks of cardiac structural remodeling

  • Winters, J.
  • von Braunmuhl, M. Edler
  • Zeemering, S.
  • Gilbers, M.
  • Brink, T. Ten
  • Scaf, B.
  • Guasch i Casany, Eduard
  • Mont Girbau, Lluís
  • Batlle, Montserrat
  • Sinner, M.
  • Hatem, S.
  • Mansour, M. K.
  • Fabritz, Larissa
  • Sommerfeld, Laura C.
  • Kirchhof, P.
  • Isaacs, A.
  • Stoll, M.
  • Schotten, Ulrich
  • Verheule, S.
Many cardiac pathologies involve changes in tissue structure. Conventional analysis of structural features is extremely time-consuming and subject to observer bias. The possibility to determine spatial interrelations between these features is often not fully exploited. We developed a staining protocol and an ImageJ-based tool (JavaCyte) for automated histological analysis of cardiac structure, including quantification of cardiomyocyte size, overall and endomysial fibrosis, spatial patterns of endomysial fibrosis, fibroblast density, capillary density and capillary size. This automated analysis was compared to manual quantification in several well-characterized goat models of atrial fibrillation (AF). In addition, we tested inter-observer variability in atrial biopsies from the CATCH-ME consortium atrial tissue bank, with patients stratified by their cardiovascular risk profile for structural remodeling. We were able to reproduce previous manually derived histological findings in goat models for AF and AV block (AVB) using JavaCyte. Furthermore, strong correlation was found between manual and automated observations for myocyte count (r = 0.94, p < 0.001), myocyte diameter (r = 0.97, p < 0.001), endomysial fibrosis (r = 0.98, p < 0.001) and capillary count (r = 0.95, p < 0.001) in human biopsies. No significant variation between observers was observed (ICC = 0.89, p < 0.001). We developed and validated an open-source tool for high-throughput, automated histological analysis of cardiac tissue properties. JavaCyte was as accurate as manual measurements, with less inter-observer variability and faster throughput.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know.

  • Guasch i Casany, Eduard
  • Mont Girbau, Lluís
  • Sitges Carreño, Marta
Exercise is an emerging cause of atrial fibrillation (AF) in young individuals without coexisting cardiovascular risk factors. The causes of exercise-induced atrial fibrillation remain largely unknown, and conclusions are jeopardised by apparently conflicting data. Some components of the athlete's heart are known to be arrhythmogenic in other settings. Bradycardia, atrial dilatation and, possibly, atrial premature beats are therefore biologically plausible contributors to exercise-induced AF. Challenging findings in an animal model suggest that exercise might also prompt the development of atrial fibrosis, possibly due to cumulative minor structural damage after each exercise bout. However, there is very limited, indirect data supporting this hypothesis in athletes. Age, sex, the presence of comorbidities and cardiovascular risk factors, and genetic individual variability might serve to flag those athletes who are at the higher risk of exercise-induced AF. In this review, we will critically address current knowledge on the mechanisms of exercise-induced AF.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Atrial fibrillation progression: How sick is the atrium?

  • Mont Girbau, Lluís
  • Guasch i Casany, Eduard
After many years of lack of interest in the atrium by clinical cardiologists, the evidence of increased morbidity and mortality in patients with atrial fibrillation (AF) relocated the atrium to a central position in cardiology more than 2 decades ago.1 First came the studies showing improved outcome with the use of anticoagulants; later, the ever-lasting controversy on rate vs rhythm control; and at present, new imaging techniques and new therapeutic tools to better define atrial remodeling and improve therapy...
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Exercise, sex and atrial fibrillation: arrhythmogenesis beyond Y-chromosome?

  • Guasch i Casany, Eduard
  • Mont Girbau, Lluís
Although prevailing research trends favour large clinical trials and registries, meticulous observation during daily clinical practice remains a valuable source for hypothesis generation in medical research. Clinical experience has allowed the identification of several risk factors in the cardiovascular field....
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Failure-free survival of the Riata implantable cardioverter-defibrillator lead after a very long-term follow-up

  • San Antonio, Rodolfo
  • Guasch i Casany, Eduard
  • Chipa Ccasani, Fredy
  • Apolo, José
  • Pujol López, Margarida
  • Fernandez, Hael
  • Trotta, Omar
  • Niebla Bellido, Mireia
  • Borràs, Roger
  • Trucco, Emilce
  • Arbelo, Elena
  • Roca Luque, Ivo
  • Brugada Terradellas, Josep, 1958-
  • Mont Girbau, Lluís
  • Tolosana, José M. (José María)
Aims: Riata® implantable cardioverter-defibrillator (ICD) leads from St. Jude Medical are prone to malfunction. This study aimed to describe the rate of this lead's malfunction in a very long-term follow-up. Methods: This single-centre observational study included 50 patients who received a Riata 7Fr dual-coil lead between 2003 and 2008. Follow-up was conducted both in person and remotely, and analysed at 8-month intervals. We evaluated the rates of cable externalization (CE), electrical failure (EF), and the interaction of these two complications. Structural lead failure was defined as radiographic CE. Oversensing of non-cardiac signal or sudden changes in impedance, sensing, or pacing thresholds constituted EF. Results: During a mean follow-up of 10.2 ± 2.9 years, 16 patients (32%) died. We observed lead malfunction in 13 patients (26%): three (23%) due to CE, six (46%) to EF and four (31%) to both complications. Of the malfunctioning leads, 77% failed after seven years of follow-up. The incidence rate (IR) of overall malfunction per 100 patients per year was 0.9 during the first seven years post-implantation, increased to 7.0 after the 7th year and more than doubled (to 16.7) after 10 years. Beyond seven years post-implantation, IR per 100 patient-years increased in both EF and CE (from 0.6 to 5.6 vs. 0.3 to 4.2, respectively). Presence of CE was associated with a 4-fold increase in the proportion of EF. Conclusion: The incidence of Riata ICD lead malfunction, both for EF and CE, increased dramatically after seven years and then more than doubled after 10 years post-implantation.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Left atrial fibrosis quantification by late gadolinium-enhanced magnetic resonance: a new method to standardize the thresholds for reproducibility

  • Benito, Eva
  • Carlosena Remirez, Alicia
  • Guasch i Casany, Eduard
  • Prat González, Susanna
  • Perea Palazón, Rosario Jesús
  • Figueras, Rosa
  • Borràs, Roger
  • Andreu, David
  • Arbelo, Elena
  • Tolosana, José M. (José María)
  • Bisbal, Felipe
  • Brugada Terradellas, Josep, 1958-
  • Berruezo Sánchez, Antonio
  • Mont Girbau, Lluís
AIMS: Identification of left atrial (LA) fibrosis through late gadolinium-enhanced cardiac magnetic resonance (LGE-CMR) remains controversial due to the heterogeneity and lack of reproducibility of proposed methods. Our aim is to describe a normalized, reproducible, standardized method to evaluate LA fibrosis through LGE-CMR. METHODS AND RESULTS: Electrocardiogram- and respiratory-gated 3-Tesla LGE-CMR was performed in 10 healthy young volunteers and 30 patients with atrial fibrillation (AF): 10 with paroxysmal AF, 10 with persistent AF, and 10 with a previous AF ablation procedure. Local image intensity ratio (IIR) of the LA was calculated as the absolute pixel intensity to mean blood pool intensity ratio. The healthy atrial tissue threshold was defined in young healthy volunteers (upper limit of normality set at IIR tissue mean plus 2 SDs). Dense atrial scarring was characterized in patients with previous radiofrequency-induced scarring (post-AF ablation patients). Validation groups consisted of patients with paroxysmal and persistent AFs. The upper limit of normal IIR was 1.20; IIR values higher than 1.32 (60% of mean maximum pixel intensity in post-ablation patients) were considered dense scar. Image intensity ratio values between 1.2 and 1.32 identified interstitial fibrosis. Patients with paroxysmal and persistent AFs had less atrial fibrotic tissue compared with post-ablation patients. Endocardial bipolar voltage was correlated to IIR values. CONCLUSIONS: An IIR of 1.2 identifies the upper limit of normality in healthy young individuals. An IIR of >1.32 defines dense atrial fibrosis in post-ablation patients. Our results provide a consistent, comparable, and normalized tool to assess atrial arrhythmogenic substrate.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Impact of left atrial volume, sphericity, and fibrosis on the outcome of catheter ablation for atrial fibrillation

  • den Uijl, Dennis W.
  • Cabanelas, Nuno
  • Benito, Eva
  • Figueras, Rosa
  • Alarcón, Francisco
  • Borràs, Roger
  • Prat González, Susanna
  • Guasch i Casany, Eduard
  • Perea Palazón, Rosario Jesús
  • Sitges Carreño, Marta
  • Brugada Terradellas, Josep, 1958-
  • Berruezo Sánchez, Antonio
  • Mont Girbau, Lluís
INTRODUCTION: To investigate the relation between left atrial (LA) volume, sphericity, and fibrotic content derived from contrast-enhanced cardiac magnetic resonance imaging (CE-CMR) and their impact on the outcome of catheter ablation for atrial fibrillation (AF). METHODS AND RESULTS: In 83 patients undergoing catheter ablation for AF, CE-CMR was used to assess LA volume, sphericity, and fibrosis. There was a significant correlation between LA volume and sphericity (R = 0.535, P < 0.001) and between LA volume and fibrosis (R = 0.241, P = 0.029). Multivariate analyses demonstrated that LA volume was the strongest independent predictor of AF recurrence after catheter ablation (1.019, P = 0.018). CONCLUSION: LA volume, sphericity, and fibrosis were closely related; however, LA volume was the strongest predictor of AF recurrence after catheter ablation.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Validity of the Polar V800 monitor for measuring heart rate variability in mountain running route conditions

  • Caminal Magrans, Pere
  • Sola, Fuensanta
  • Gomis, Pedro
  • Guasch i Casany, Eduard
  • Perera Lluna, Alexandre
  • Soriano, Núria
  • Mont Girbau, Lluís
PURPOSE: This study was conducted to test, in mountain running route conditions, the accuracy of the Polar V800 monitor as a suitable device for monitoring the heart rate variability (HRV) of runners. METHOD: Eighteen healthy subjects ran a route that included a range of running slopes such as those encountered in trail and ultra-trail races. The comparative study of a V800 and a Holter SEER 12 ECG Recorder included the analysis of RR time series and short-term HRV analysis. A correction algorithm was designed to obtain the corrected Polar RR intervals. Six 5-min segments related to different running slopes were considered for each subject. RESULTS: The correlation between corrected V800 RR intervals and Holter RR intervals was very high (r = 0.99, p < 0.001), and the bias was less than 1 ms. The limits of agreement (LoA) obtained for SDNN and RMSSD were (- 0.25 to 0.32 ms) and (- 0.90 to 1.08 ms), respectively. The effect size (ES) obtained in the time domain HRV parameters was considered small (ES < 0.2). Frequency domain HRV parameters did not differ (p > 0.05) and were well correlated (r ≥ 0.96, p < 0.001). CONCLUSION: Narrow limits of agreement, high correlations and small effect size suggest that the Polar V800 is a valid tool for the analysis of heart rate variability in athletes while running high endurance events such as marathon, trail, and ultra-trail races. KEYWORDS: HRV; Open field running conditions; Polar V800 heart rate monitor; Validation
UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Validity of the Polar V800 monitor for measuring heart rate variability in mountain running route conditions

  • Caminal Magrans, Pere|||0000-0002-2301-8153
  • Sola Almirón, Fuensanta
  • Gomis Román, Pedro|||0000-0002-2058-7115
  • Guasch, Eduard
  • Perera Lluna, Alexandre|||0000-0001-6427-851X
  • Mont Girbau, Lluis
Purpose This study was conducted to test, in mountain running route conditions, the accuracy of the Polar V800™ monitor as a suitable device for monitoring the heart rate variability (HRV) of runners. Method Eighteen healthy subjects ran a route that included a range of running slopes such as those encountered in trail and ultra-trail races. The comparative study of a V800 and a Holter SEER 12 ECG Recorder™ included the analysis of RR time series and short-term HRV analysis. A correction algorithm was designed to obtain the corrected Polar RR intervals. Six 5-min segments related to different running slopes were considered for each subject. Results The correlation between corrected V800 RR intervals and Holter RR intervals was very high (r¿=¿0.99, p¿<¿0.001), and the bias was less than 1 ms. The limits of agreement (LoA) obtained for SDNN and RMSSD were (-¿0.25 to 0.32 ms) and (-¿0.90 to 1.08 ms), respectively. The effect size (ES) obtained in the time domain HRV parameters was considered small (ES¿<¿0.2). Frequency domain HRV parameters did not differ (p¿>¿0.05) and were well correlated (r¿=¿0.96, p¿<¿0.001). Conclusion Narrow limits of agreement, high correlations and small effect size suggest that the Polar V800 is a valid tool for the analysis of heart rate variability in athletes while running high endurance events such as marathon, trail, and ultra-trail races., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Validity of the Polar V800 monitor for measuring heart rate variability in mountain running route conditions

  • Caminal Magrans, Pere
  • Sola Almirón, Fuensanta
  • Gomis Román, Pedro
  • Guasch, Eduard
  • Perera Lluna, Alexandre
  • Mont Girbau, Lluis
Purpose This study was conducted to test, in mountain running route conditions, the accuracy of the Polar V800™ monitor as a suitable device for monitoring the heart rate variability (HRV) of runners. Method Eighteen healthy subjects ran a route that included a range of running slopes such as those encountered in trail and ultra-trail races. The comparative study of a V800 and a Holter SEER 12 ECG Recorder™ included the analysis of RR time series and short-term HRV analysis. A correction algorithm was designed to obtain the corrected Polar RR intervals. Six 5-min segments related to different running slopes were considered for each subject. Results The correlation between corrected V800 RR intervals and Holter RR intervals was very high (r¿=¿0.99, p¿<¿0.001), and the bias was less than 1 ms. The limits of agreement (LoA) obtained for SDNN and RMSSD were (-¿0.25 to 0.32 ms) and (-¿0.90 to 1.08 ms), respectively. The effect size (ES) obtained in the time domain HRV parameters was considered small (ES¿<¿0.2). Frequency domain HRV parameters did not differ (p¿>¿0.05) and were well correlated (r¿=¿0.96, p¿<¿0.001). Conclusion Narrow limits of agreement, high correlations and small effect size suggest that the Polar V800 is a valid tool for the analysis of heart rate variability in athletes while running high endurance events such as marathon, trail, and ultra-trail races., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Left atrial fibrosis quantification by late gadolinium-enhanced magnetic resonance: a new method to standardize the thresholds for reproducibility

  • Benito, Eva
  • Carlosena Remirez, Alicia
  • Guasch i Casany, Eduard
  • Prat González, Susanna
  • Perea Palazón, Rosario Jesús
  • Figueras, Rosa
  • Borràs, Roger
  • Andreu, David
  • Arbelo, Elena
  • Tolosana, José M. (José María)
  • Bisbal, Felipe
  • Brugada Terradellas, Josep, 1958-
  • Berruezo Sánchez, Antonio
  • Mont Girbau, Lluís
AIMS: Identification of left atrial (LA) fibrosis through late gadolinium-enhanced cardiac magnetic resonance (LGE-CMR) remains controversial due to the heterogeneity and lack of reproducibility of proposed methods. Our aim is to describe a normalized, reproducible, standardized method to evaluate LA fibrosis through LGE-CMR. METHODS AND RESULTS: Electrocardiogram- and respiratory-gated 3-Tesla LGE-CMR was performed in 10 healthy young volunteers and 30 patients with atrial fibrillation (AF): 10 with paroxysmal AF, 10 with persistent AF, and 10 with a previous AF ablation procedure. Local image intensity ratio (IIR) of the LA was calculated as the absolute pixel intensity to mean blood pool intensity ratio. The healthy atrial tissue threshold was defined in young healthy volunteers (upper limit of normality set at IIR tissue mean plus 2 SDs). Dense atrial scarring was characterized in patients with previous radiofrequency-induced scarring (post-AF ablation patients). Validation groups consisted of patients with paroxysmal and persistent AFs. The upper limit of normal IIR was 1.20; IIR values higher than 1.32 (60% of mean maximum pixel intensity in post-ablation patients) were considered dense scar. Image intensity ratio values between 1.2 and 1.32 identified interstitial fibrosis. Patients with paroxysmal and persistent AFs had less atrial fibrotic tissue compared with post-ablation patients. Endocardial bipolar voltage was correlated to IIR values. CONCLUSIONS: An IIR of 1.2 identifies the upper limit of normality in healthy young individuals. An IIR of >1.32 defines dense atrial fibrosis in post-ablation patients. Our results provide a consistent, comparable, and normalized tool to assess atrial arrhythmogenic substrate.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Validity of the Polar V800 monitor for measuring heart rate variability in mountain running route conditions

  • Caminal Magrans, Pere
  • Sola, Fuensanta
  • Gomis, Pedro
  • Guasch i Casany, Eduard
  • Perera Lluna, Alexandre
  • Soriano, Núria
  • Mont Girbau, Lluís
PURPOSE: This study was conducted to test, in mountain running route conditions, the accuracy of the Polar V800 monitor as a suitable device for monitoring the heart rate variability (HRV) of runners. METHOD: Eighteen healthy subjects ran a route that included a range of running slopes such as those encountered in trail and ultra-trail races. The comparative study of a V800 and a Holter SEER 12 ECG Recorder included the analysis of RR time series and short-term HRV analysis. A correction algorithm was designed to obtain the corrected Polar RR intervals. Six 5-min segments related to different running slopes were considered for each subject. RESULTS: The correlation between corrected V800 RR intervals and Holter RR intervals was very high (r = 0.99, p < 0.001), and the bias was less than 1 ms. The limits of agreement (LoA) obtained for SDNN and RMSSD were (- 0.25 to 0.32 ms) and (- 0.90 to 1.08 ms), respectively. The effect size (ES) obtained in the time domain HRV parameters was considered small (ES < 0.2). Frequency domain HRV parameters did not differ (p > 0.05) and were well correlated (r ≥ 0.96, p < 0.001). CONCLUSION: Narrow limits of agreement, high correlations and small effect size suggest that the Polar V800 is a valid tool for the analysis of heart rate variability in athletes while running high endurance events such as marathon, trail, and ultra-trail races. KEYWORDS: HRV; Open field running conditions; Polar V800 heart rate monitor; Validation
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Impact of left atrial volume, sphericity, and fibrosis on the outcome of catheter ablation for atrial fibrillation

  • den Uijl, Dennis W.
  • Cabanelas, Nuno
  • Benito, Eva
  • Figueras, Rosa
  • Alarcón, Francisco
  • Borràs, Roger
  • Prat González, Susanna
  • Guasch i Casany, Eduard
  • Perea Palazón, Rosario Jesús
  • Sitges Carreño, Marta
  • Brugada Terradellas, Josep, 1958-
  • Berruezo Sánchez, Antonio
  • Mont Girbau, Lluís
INTRODUCTION: To investigate the relation between left atrial (LA) volume, sphericity, and fibrotic content derived from contrast-enhanced cardiac magnetic resonance imaging (CE-CMR) and their impact on the outcome of catheter ablation for atrial fibrillation (AF). METHODS AND RESULTS: In 83 patients undergoing catheter ablation for AF, CE-CMR was used to assess LA volume, sphericity, and fibrosis. There was a significant correlation between LA volume and sphericity (R = 0.535, P < 0.001) and between LA volume and fibrosis (R = 0.241, P = 0.029). Multivariate analyses demonstrated that LA volume was the strongest independent predictor of AF recurrence after catheter ablation (1.019, P = 0.018). CONCLUSION: LA volume, sphericity, and fibrosis were closely related; however, LA volume was the strongest predictor of AF recurrence after catheter ablation.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Preferential regional distribution of atrial fibrosis in posterior wall around left inferior pulmonary vein as identified by late gadolinium enhancement cardiac magnetic resonance in patients with atrial fibrillation

  • Benito, Eva M.
  • Cabanelas, Nuno
  • Nuñez-Garcia, Marta
  • Alarcón, Francisco
  • Figueras i Ventura, Rosa M.
  • Soto-Iglesias, David
  • Guasch, Eduard
  • Prat Gonzàlez, Susanna
  • Perea, Rosario J.
  • Borràs, Roger
  • Butakoff, Constantine
  • Camara, Oscar
  • Bisbal, Felipe
  • Arbelo, Elena
  • Tolosana, José Maria
  • Brugada, Josep
  • Berruezo Sánchez, Antonio
  • Mont, Lluís
Aims: Left atrial (LA) fibrosis can be identified by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) in patients with atrial fibrillation (AF). However, there is limited information about anatomical fibrosis distribution in the left atrium. The aim is to determine whether there is a preferential spatial distribution of fibrosis in the left atrium in patients with AF. Methods and results: A 3-Tesla LGE-CMR was performed in 113 consecutive patients referred for AF ablation. Images were post-processed and analysed using ADAS-AF software (Galgo Medical), which allows fibrosis identification in 3D colour-coded shells. A regional semiautomatic LA parcellation software was used to divide the atrial wall into 12 segments: 1–4, posterior wall; 5–6, floor; 7, septal wall; 8–11, anterior wall; 12, lateral wall. The presence and amount of fibrosis in each segment was obtained for analysis. After exclusions for artefacts and insufficient image quality, 76 LGE-MRI images (68%) were suitable for fibrosis analysis. Segments 3 and 5, closest to the left inferior pulmonary vein, had significantly higher fibrosis (40.42% ± 23.96 and 25.82% ± 21.24, respectively; P < 0.001), compared with other segments. Segments 8 and 10 in the anterior wall contained the lowest fibrosis (2.54% ± 5.78 and 3.82% ± 11.59, respectively; P < 0.001). Age >60 years was significantly associated with increased LA fibrosis [95% confidence interval (CI) 0.19–8.39, P = 0.04] and persistent AF approached significance (95% CI −0.19% to 7.83%, P = 0.08). Conclusion: In patients with AF, the fibrotic area is preferentially located at the posterior wall and floor around the antrum of the left inferior pulmonary vein. Age >60 years was associated with increased fibrosis., This work was partially supported by Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III (PI13/01747 and PI16/00435); Agencia de gestió d´Ajuts Universitaris I de Recerca (AGAUR) Exp: 2014_SGR_471; CERCA programme/Generalitat de Catalunya; European Regional Development Fund (ERDF. European Union. A Way of Making Europe), the European Union's Horizon 2020 research and innovation programme under grant agreement No 633196 (CATCH ME), a grant by La MARATÓ-TV3 (20152730) and the Spanish Ministry of Economy and Competitiveness (DPI2015-71640-R).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Emerging risk factors and the dose-response relationship between physical activity and lone atrial fibrillation: a prospective case-control study

  • Calvo Galiano, Naiara
  • Ramos, Pablo
  • Montserrat-Vila, Sílvia
  • Guasch i Casany, Eduard
  • Coll-Vinent i Puig, Blanca
  • Doménech, Mónica
  • Bisbal, Felipe
  • Hevia, Sara
  • Vidorreta, Silvia
  • Borràs, Roger
  • Falces Salvador, Carles
  • Embid, Cristina
  • Montserrat Canal, José Ma.
  • Berruezo Sánchez, Antonio
  • Coca, Antonio
  • Sitges Carreño, Marta
  • Brugada Terradellas, Josep, 1958-
  • Mont Girbau, Lluís
A history of a parts per thousand yen2000 h of vigorous endurance training, tall stature, abdominal obesity, and OSA are frequently encountered as risk factors in patients with Ln-AF. Fewer than 2000 total hours of high-intensity endurance training associates with reduced Ln-AF risk.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Exercise, sex and atrial fibrillation: arrhythmogenesis beyond Y-chromosome?

  • Guasch i Casany, Eduard
  • Mont Girbau, Lluís
Although prevailing research trends favour large clinical trials and registries, meticulous observation during daily clinical practice remains a valuable source for hypothesis generation in medical research. Clinical experience has allowed the identification of several risk factors in the cardiovascular field....
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Preferential regional distribution of atrial fibrosis in posterior wall around left inferior pulmonary vein as identified by late gadolinium enhancement cardíac magnetic resonance in patients with atrial fibrillation

  • Benito, Eva
  • Cabanelas, Nuno
  • Nuñez-Garcia, Marta
  • Alarcón, Francisco
  • Figueras i Ventura, Rosa M.
  • Soto Iglesias, David
  • Guasch i Casany, Eduard
  • Prat González, Susanna
  • Perea Palazón, Rosario Jesús
  • Borràs, Roger
  • Butakoff, Constantine
  • Camara, Oscar
  • Bisbal, Felipe
  • Arbelo, Elena
  • Tolosana, José M. (José María)
  • Brugada Terradellas, Josep, 1958-
  • Berruezo Sánchez, Antonio
  • Mont Girbau, Lluís
Aims: Left atrial (LA) fibrosis can be identified by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) in patients with atrial fibrillation (AF). However, there is limited information about anatomical fibrosis distribution in the left atrium. The aim is to determine whether there is a preferential spatial distribution of fibrosis in the left atrium in patients with AF. Methods and results: A 3-Tesla LGE-CMR was performed in 113 consecutive patients referred for AF ablation. Images were post-processed and analysed using ADAS-AF software (Galgo Medical), which allows fibrosis identification in 3D colour-coded shells. A regional semiautomatic LA parcellation software was used to divide the atrial wall into 12 segments: 1-4, posterior wall; 5-6, floor; 7, septal wall; 8-11, anterior wall; 12, lateral wall. The presence and amount of fibrosis in each segment was obtained for analysis. After exclusions for artefacts and insufficient image quality, 76 LGE-MRI images (68%) were suitable for fibrosis analysis. Segments 3 and 5, closest to the left inferior pulmonary vein, had significantly higher fibrosis (40.42% ± 23.96 and 25.82% ± 21.24, respectively; P < 0.001), compared with other segments. Segments 8 and 10 in the anterior wall contained the lowest fibrosis (2.54% ± 5.78 and 3.82% ± 11.59, respectively; P < 0.001). Age >60 years was significantly associated with increased LA fibrosis [95% confidence interval (CI) 0.19-8.39, P = 0.04] and persistent AF approached significance (95% CI -0.19% to 7.83%, P = 0.08). Conclusion: In patients with AF, the fibrotic area is preferentially located at the posterior wall and floor around the antrum of the left inferior pulmonary vein. Age >60 years was associated with increased fibrosis.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Diagnosis, pathophysiology, and management of exercise-induced arrhythmias

  • Guasch i Casany, Eduard
  • Mont Girbau, Lluís
The cardiovascular benefits of physical activity are indisputable. Nevertheless, growing evidence suggests that both atrial fibrillation and right ventricular arrhythmia can be caused by intense exercise in some individuals. Exercise-induced atrial fibrillation is most commonly diagnosed in middle-aged, otherwise healthy men who have been engaged in endurance training for >10 years, and is mediated by atrial dilatation, parasympathetic enhancement, and possibly atrial fibrosis. Cardiac ablation is evolving as a first-line tool for athletes with exercise-induced arrhythmia who are eager to remain active. The relationship between physical activity and right ventricular arrhythmia is complex and involves genetic and physical factors that, in a few athletes, eventually lead to right ventricular dilatation, followed by subsequent myocardial fibrosis and lethal ventricular arrhythmias. Sinus bradycardia and atrioventricular conduction blocks are common in athletes, most of whom remain asymptomatic, although incomplete reversibility has been shown after exercise cessation. In this Review, we summarize the evidence supporting the existence of exercise-induced arrhythmias and discuss the specific considerations for the clinical management of these patients.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know.

  • Guasch i Casany, Eduard
  • Mont Girbau, Lluís
  • Sitges Carreño, Marta
Exercise is an emerging cause of atrial fibrillation (AF) in young individuals without coexisting cardiovascular risk factors. The causes of exercise-induced atrial fibrillation remain largely unknown, and conclusions are jeopardised by apparently conflicting data. Some components of the athlete's heart are known to be arrhythmogenic in other settings. Bradycardia, atrial dilatation and, possibly, atrial premature beats are therefore biologically plausible contributors to exercise-induced AF. Challenging findings in an animal model suggest that exercise might also prompt the development of atrial fibrosis, possibly due to cumulative minor structural damage after each exercise bout. However, there is very limited, indirect data supporting this hypothesis in athletes. Age, sex, the presence of comorbidities and cardiovascular risk factors, and genetic individual variability might serve to flag those athletes who are at the higher risk of exercise-induced AF. In this review, we will critically address current knowledge on the mechanisms of exercise-induced AF.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study

  • Bisbal, Felipe
  • Alarcón, Francisco
  • Ferrero, Ángel
  • González Ferrer, Juan José
  • Alonso, Concepción
  • Pachón, Marta
  • Tizón Marcos, Helena
  • Cabanas Grandío, Pilar
  • Sánchez, Manuel
  • Benito, Eva
  • Teis, Albert
  • Ruiz Granell, Ricardo
  • Pérez Villacastín, Julián
  • Viñolas, Xavier
  • Arias, Miguel Ángel
  • Vallès, Ermengol
  • García Campo, Enrique
  • Fernández Lozano, Ignacio
  • Villuendas, Roger
  • Mont Girbau, Lluís
Aims: Left atrial (LA) remodelling is a key determinant of atrial fibrillation (AF) ablation outcome. Optimal methods to assess this process are scarce. LA sphericity is a shape-based parameter shown to be independently associated to procedural success. In a multicentre study, we aimed to test the feasibility of assessing LA sphericity and evaluate its capability to predict procedural outcomes. Methods and results: This study included consecutive patients undergoing first AF ablation during 2013. A 3D model of the LA chamber, excluding pulmonary veins and LA appendage, was used to quantify LA volume (LAV) and LA sphericity (≥82.1% was considered spherical LA). In total, 243 patients were included across 9 centres (71% men, aged 56 ± 10 years, 44% with hypertension and 76% CHA2DS2-VASc ≤ 1). Most patients had paroxysmal AF (66%) and underwent radiofrequency ablation (60%). Mean LA diameter (LAD), LAV, and LA sphericity were 42 ± 6 mm, 100 ± 33 mL, and 82.6 ± 3.5%, respectively. Adjusted Cox models identified paroxysmal AF [hazard ratio (HR 0.54, P = 0.032)] and LA sphericity (HR 1.87, P = 0.035) as independent predictors for AF recurrence. A combined clinical-imaging score [Left Atrial Geometry and Outcome (LAGO)] including five items (AF phenotype, structural heart disease, CHA2DS2-VASc ≤ 1, LAD, and LA sphericity) classified patients at low (≤2 points) and high risk (≥3 points) of procedural failure (35% vs. 82% recurrence at 3-year follow-up, respectively; HR 3.10, P < 0.001). Conclusion: In this multicentre, real-life cohort, LA sphericity and AF phenotype were the strongest predictors of AF ablation outcome after adjustment for covariates. The LAGO score was easy to implement, identified high risk of procedural failure, and could help select optimal candidates. Clinical Trial Registration Information: NCT02373982 (http://clinicaltrials.gov/ct2/show/NCT02373982).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

JavaCyte, a novel open-source tool for automated quantification of key hallmarks of cardiac structural remodeling

  • Winters, J.
  • von Braunmuhl, M. Edler
  • Zeemering, S.
  • Gilbers, M.
  • Brink, T. Ten
  • Scaf, B.
  • Guasch i Casany, Eduard
  • Mont Girbau, Lluís
  • Batlle, Montserrat
  • Sinner, M.
  • Hatem, S.
  • Mansour, M. K.
  • Fabritz, Larissa
  • Sommerfeld, Laura C.
  • Kirchhof, P.
  • Isaacs, A.
  • Stoll, M.
  • Schotten, Ulrich
  • Verheule, S.
Many cardiac pathologies involve changes in tissue structure. Conventional analysis of structural features is extremely time-consuming and subject to observer bias. The possibility to determine spatial interrelations between these features is often not fully exploited. We developed a staining protocol and an ImageJ-based tool (JavaCyte) for automated histological analysis of cardiac structure, including quantification of cardiomyocyte size, overall and endomysial fibrosis, spatial patterns of endomysial fibrosis, fibroblast density, capillary density and capillary size. This automated analysis was compared to manual quantification in several well-characterized goat models of atrial fibrillation (AF). In addition, we tested inter-observer variability in atrial biopsies from the CATCH-ME consortium atrial tissue bank, with patients stratified by their cardiovascular risk profile for structural remodeling. We were able to reproduce previous manually derived histological findings in goat models for AF and AV block (AVB) using JavaCyte. Furthermore, strong correlation was found between manual and automated observations for myocyte count (r = 0.94, p < 0.001), myocyte diameter (r = 0.97, p < 0.001), endomysial fibrosis (r = 0.98, p < 0.001) and capillary count (r = 0.95, p < 0.001) in human biopsies. No significant variation between observers was observed (ICC = 0.89, p < 0.001). We developed and validated an open-source tool for high-throughput, automated histological analysis of cardiac tissue properties. JavaCyte was as accurate as manual measurements, with less inter-observer variability and faster throughput.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Atrial fibrillation progression: How sick is the atrium?

  • Mont Girbau, Lluís
  • Guasch i Casany, Eduard
After many years of lack of interest in the atrium by clinical cardiologists, the evidence of increased morbidity and mortality in patients with atrial fibrillation (AF) relocated the atrium to a central position in cardiology more than 2 decades ago.1 First came the studies showing improved outcome with the use of anticoagulants; later, the ever-lasting controversy on rate vs rhythm control; and at present, new imaging techniques and new therapeutic tools to better define atrial remodeling and improve therapy...
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset

  • Chua, Winnie
  • Easter, Christina L.
  • Guasch i Casany, Eduard
  • Sitch, Alice
  • Casadei, Barabara
  • Crijns, Harry J.G.M.
  • Haase, Doreen
  • Hatem Stéphane
  • Kääb, Stefan
  • Mont Girbau, Lluís
  • Schotten, Ulrich
  • Sinner, Moritz F.
  • Hemming, Karla
  • Deeks, Jonathan J.
  • Kirchhof, Paulus
  • Fabritz, Larissa
Background: Atrial fibrillation (AF) is caused by different mechanisms but current treatment strategies do not target these mechanisms. Stratified therapy based on mechanistic drivers and biomarkers of AF have the potential to improve AF prevention and management outcomes. We will integrate mechanistic insights with known pathophysiological drivers of AF in models predicting recurrent AF and prevalent AF to test hypotheses related to AF mechanisms and response to rhythm control therapy. Methods: We will harmonise and combine baseline and outcome data from 12 studies collected by six centres from the United Kingdom, Germany, France, Spain, and the Netherlands which assess prevalent AF or recurrent AF. A Delphi process and statistical selection will be used to identify candidate clinical predictors. Prediction models will be developed in patients with AF for AF recurrence and AF-related outcomes, and in patients with or without AF at baseline for prevalent AF. Models will be used to test mechanistic hypotheses and investigate the predictive value of plasma biomarkers. Discussion: This retrospective, harmonised, individual patient data analysis will use information from 12 datasets collected in five European countries. It is envisioned that the outcome of this analysis would provide a greater understanding of the factors associated with recurrent and prevalent AF, potentially allowing development of stratified approaches to prevention and therapy management.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Failure-free survival of the Riata implantable cardioverter-defibrillator lead after a very long-term follow-up

  • San Antonio, Rodolfo
  • Guasch i Casany, Eduard
  • Chipa Ccasani, Fredy
  • Apolo, José
  • Pujol López, Margarida
  • Fernandez, Hael
  • Trotta, Omar
  • Niebla Bellido, Mireia
  • Borràs, Roger
  • Trucco, Emilce
  • Arbelo, Elena
  • Roca Luque, Ivo
  • Brugada Terradellas, Josep, 1958-
  • Mont Girbau, Lluís
  • Tolosana, José M. (José María)
Aims: Riata® implantable cardioverter-defibrillator (ICD) leads from St. Jude Medical are prone to malfunction. This study aimed to describe the rate of this lead's malfunction in a very long-term follow-up. Methods: This single-centre observational study included 50 patients who received a Riata 7Fr dual-coil lead between 2003 and 2008. Follow-up was conducted both in person and remotely, and analysed at 8-month intervals. We evaluated the rates of cable externalization (CE), electrical failure (EF), and the interaction of these two complications. Structural lead failure was defined as radiographic CE. Oversensing of non-cardiac signal or sudden changes in impedance, sensing, or pacing thresholds constituted EF. Results: During a mean follow-up of 10.2 ± 2.9 years, 16 patients (32%) died. We observed lead malfunction in 13 patients (26%): three (23%) due to CE, six (46%) to EF and four (31%) to both complications. Of the malfunctioning leads, 77% failed after seven years of follow-up. The incidence rate (IR) of overall malfunction per 100 patients per year was 0.9 during the first seven years post-implantation, increased to 7.0 after the 7th year and more than doubled (to 16.7) after 10 years. Beyond seven years post-implantation, IR per 100 patient-years increased in both EF and CE (from 0.6 to 5.6 vs. 0.3 to 4.2, respectively). Presence of CE was associated with a 4-fold increase in the proportion of EF. Conclusion: The incidence of Riata ICD lead malfunction, both for EF and CE, increased dramatically after seven years and then more than doubled after 10 years post-implantation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Estimated Population Prevalence of Heart Failure with Reduced Ejection Fraction in Spain, According to DAPA-HF Study Criteria

  • Camps-Vilaró, Anna|||0000-0001-9644-8421
  • Delgado-Jiménez, Juan Francisco|||0000-0002-5401-8324
  • Farré, Núria|||0000-0003-3110-6572
  • Tizón-Marcos, Helena|||0000-0001-7942-9413
  • Alvarez-Garcia, Jesus|||0000-0002-2015-6446
  • Cinca, Juan|||0000-0003-4819-4265
  • Degano, Irene R.|||0000-0003-1914-6934
  • Marrugat, Jaume|||0000-0003-3320-554X
Heart failure (HF) is one of the main causes of morbidity, mortality, and high healthcare costs. Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, reduced cardiovascular mortality and hospitalization for HF compared to placebo in patients with chronic HF, and reduced ejection fraction (EF) in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) study. Our aim was to estimate the number of patients with DAPA-HF characteristics in Spain. Our literature review identified epidemiological studies whose objective was to quantify the prevalence of HF and its comorbidities in Spain. We estimated the prevalence of HF with reduced EF, of New York Heart Association (NYHA) functional class II-IV, and with a glomerular filtration rate (GFR) ≥ 30 mL/min/1.73 m². In this population, we analysed the prevalence of diabetes using data from the REDINSCOR (Spanish Network for Heart Failure) registry. Our estimations indicate there are 594,684 patients ≥45 years old with HF in Spain (2.6% of this population age group), of which 52.4%, 84.0%, and 93.9% have reduced EF, are NYHA II-IV, and have a GFR ≥ 30 mL/min/1.73 m², respectively. By our calculations, approximately 245,789 Spanish patients would meet the DAPA-HF patient profile, and therefore could benefit from the protective cardiovascular effects of dapagliflozin.